SK187899A3 - Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches - Google Patents

Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches Download PDF

Info

Publication number
SK187899A3
SK187899A3 SK1878-99A SK187899A SK187899A3 SK 187899 A3 SK187899 A3 SK 187899A3 SK 187899 A SK187899 A SK 187899A SK 187899 A3 SK187899 A3 SK 187899A3
Authority
SK
Slovakia
Prior art keywords
headache
local anesthetic
patient
administration
pain
Prior art date
Application number
SK1878-99A
Other languages
English (en)
Slovak (sk)
Inventor
Bruce H Levin
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK187899A3 publication Critical patent/SK187899A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1878-99A 1997-07-21 1998-07-17 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches SK187899A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89719297A 1997-07-21 1997-07-21
US7284598P 1998-01-28 1998-01-28
US8455998P 1998-05-06 1998-05-06
PCT/US1998/014870 WO1999003473A1 (en) 1997-07-21 1998-07-17 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches

Publications (1)

Publication Number Publication Date
SK187899A3 true SK187899A3 (en) 2000-12-11

Family

ID=27372174

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1878-99A SK187899A3 (en) 1997-07-21 1998-07-17 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches

Country Status (20)

Country Link
EP (1) EP0999839B1 (ko)
JP (1) JP4521117B2 (ko)
KR (1) KR20010022041A (ko)
CN (1) CN1267219A (ko)
AR (1) AR013240A1 (ko)
AT (1) ATE269702T1 (ko)
AU (1) AU8574398A (ko)
BR (1) BR9810773A (ko)
CA (1) CA2297097C (ko)
DE (1) DE69824730T2 (ko)
EE (1) EE200000050A (ko)
HU (1) HUP0003953A3 (ko)
ID (1) ID24903A (ko)
IL (2) IL134087A0 (ko)
IS (1) IS5349A (ko)
NO (1) NO20000293L (ko)
PL (1) PL338176A1 (ko)
SK (1) SK187899A3 (ko)
TR (1) TR200000149T2 (ko)
WO (1) WO1999003473A1 (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
JP4632499B2 (ja) * 1999-08-26 2011-02-16 武田薬品工業株式会社 鼻粘膜付着マトリックス
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US6853858B2 (en) 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
US7769461B2 (en) 2003-12-19 2010-08-03 Boston Scientific Neuromodulation Corporation Skull-mounted electrical stimulation system and method for treating patients
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US7592371B2 (en) 2004-08-18 2009-09-22 Medrx Co., Ltd. External preparation
KR101367479B1 (ko) * 2008-07-21 2014-03-14 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 귀 질병 치료를 위한 제어 방출형 항미생물성 조성물 및 방법
DE102008037682A1 (de) 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
CA2885749A1 (en) 2012-09-28 2014-04-03 St. Renatus, Llc Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
CN103432378A (zh) * 2013-08-15 2013-12-11 吕清华 一种治疗神经血管性头痛的中药
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3093043B1 (en) 2015-05-13 2018-11-14 Brainsgate Ltd. Implant and delivery system for neural stimulator
US20220096452A1 (en) * 2019-01-22 2022-03-31 Icm (Institut Du Cerveau Et De La Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions
GB2628149A (en) * 2023-03-16 2024-09-18 Lee Nathaniel Wurie Nasal spray for performing sphenopalatine ganglion block

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
DE19526019A1 (de) * 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen
BE1009851A3 (fr) * 1996-01-11 1997-10-07 Thiebauld Charles Marie Composition pharmaceutique pour le traitement des cephalees et son utilisation.
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use

Also Published As

Publication number Publication date
IS5349A (is) 2000-01-18
IL134087A (en) 2006-10-31
CN1267219A (zh) 2000-09-20
WO1999003473A1 (en) 1999-01-28
NO20000293D0 (no) 2000-01-20
PL338176A1 (en) 2000-10-09
KR20010022041A (ko) 2001-03-15
NO20000293L (no) 2000-03-20
HUP0003953A3 (en) 2002-02-28
ID24903A (id) 2000-08-31
AU8574398A (en) 1999-02-10
EE200000050A (et) 2000-10-16
ATE269702T1 (de) 2004-07-15
CA2297097C (en) 2009-04-07
TR200000149T2 (tr) 2000-05-22
DE69824730T2 (de) 2005-07-14
EP0999839B1 (en) 2004-06-23
JP2001513483A (ja) 2001-09-04
IL134087A0 (en) 2001-04-30
BR9810773A (pt) 2000-09-19
AR013240A1 (es) 2000-12-13
CA2297097A1 (en) 1999-01-28
DE69824730D1 (de) 2004-07-29
HUP0003953A1 (hu) 2002-01-28
EP0999839A1 (en) 2000-05-17
JP4521117B2 (ja) 2010-08-11

Similar Documents

Publication Publication Date Title
US6432986B2 (en) Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US9302096B2 (en) Apparatus for treating cerebral neurovascular disorders including headaches by neural stimulation
US6491940B1 (en) Apparatus for administering composition for inhibiting cerebral neurovascular disorders and muscular headaches
US20010004644A1 (en) Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
US20050281751A1 (en) Directed intranasal administration of pharmaceutical agents
EP0999839B1 (en) Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US20160030408A1 (en) Materials and methods for treating neuropathies and related disorders including those involving a keystone nerve
US11541237B2 (en) Methods for improving shoulder range of motion and functionality
JP6200648B2 (ja) 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物
JP2006515327A (ja) ナトリウムチャネル調節因子を用いた下部尿路障害を処置するための方法
WO2001043733A2 (en) Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
WO1999032103A1 (en) New use of local anaesthetics against vascular headaches
CZ2000215A3 (cs) Kompozice, kity a způsoby pro inhibici cerebrálních neurovaskuiárních poruch a svalové bolestí hlavy
MXPA00000705A (en) Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
Hosal et al. A rationale for the selection of nasal decongestants in lacrimal drainage surgery
Kumar Perspectives on Local Anesthetics in Medicine
Helgeson et al. Section 5 Local Anesthetics Chapter 64
Steven Padilla Anesthesia for Dermatologic Surgery.